Global Dermal Fillers Facial Aesthetics Market By Type (HA Dermal Fillers {Monophasic HA Fillers, Biphasic HA Fillers}, Non-HA Dermal Fillers {Polymethylmethacrylate (PMMA) Filler, Collagen, Poly-L-Lactic Acid (PLLA), Calcium Hydroxylapatite (CaHA)}), By Application (Wrinkles, Lip Enhancement, Facial Contouring, Glabellar Furrows, Peri-Orbital, Others (Scars, Crow's Feet, Etc.) By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Portugal, Poland, Nordic { Denmark, Finland, Iceland, Norway, Sweden, Rest of Nordic}, Ukraine, The Benelux Union {Belgium, the Netherlands, Luxemburg}, Rest of Europe, China, Japan, India, Australia, New Zealand, Hong Kong, Singapore, Taiwan, Malaysia, Russia, Southeast Asia, Rest of Asia Pacific, GCC Countries, UAE, Saudi Arabia, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027

Report ID :AMI-161 | Category : Healthcare | Published Date : February, 2019 | Pages : 402 | Format :PDF
Buy Now!

Industry Trends:

Dermal fillers facial aesthetics is a therapy of injecting soft tissue into facial skin to infill facial wrinkles and restore smoother appearance. The two prominent variants of dermal fillers are Hyaluronic acid (HA) dermal fillers and non-Hyaluronic acid dermal fillers. HA dermal fillers is predominantly preferred owing to its natural compatibility features with human skin. Moreover, the use of HA as dermal fillers have reported least number of hypersensitive reactions and also do not have any organ or species specificity. Further, reverse effects of the treatment made through HA dermal fillers are also possible, as against the treatment done through non-HA dermal fillers where reverse-effects are not possible, making it increasingly popular globally.

Dermal filler treatment is largely undertaken for lip enhancement, facial contouring, glabellar furrows, peri-orbital and to correct wrinkles amongst others. Increased influence among mid age women towards enhanced physical appearance along with increased beauty awareness is triggering the growth of dermal fillers facial aesthetics market. Innovations on different techniques for altering and enhancing facial aesthetics in gender-specific appearance is also emerging as a major trend in the global market. Growing demand for layering technique and volume contouring of different areas in the face including midcheek, periorbital region is steadily gaining popularity and is expected to drive the global dermal fillers facial aesthetic market over the forecast period.

The global dermal fillers facial aesthetics market, revenue stood at US$ 5,348.98 Million in year 2018 and is expected to grow at a CAGR of more than 8% during the forecast period of 2019 - 2027.

The overall shift in the facial rejuvenation approach, i.e., from subtractive surgical method to additive volume restoration techniques is gaining popularity and is also dominating the demand for global dermal fillers facial aesthetics market. The preference for facial contouring using dermal fillers is on a surge and is also expected to boost the global dermal fillers facial aesthetics market over the next eight years. The treatment is being largely undertaken by people in the age group of 35 to 50 years, which signifies that a greater preference is given to prevention and maintenance over correction. The application of dermal filler treatment for wrinkle reduction is expected to showcase highest growth rate over the next eight years.

The patients undergoing dermal fillers facial aesthetics treatment are prone to certain side effects such as redness, swelling, pain, itching and bruising at the injection site. In order to address the situation, industry participants are introducing innovative solutions for facial aesthetic procedures. In April 2019, Merz Pharma, a German-based pharmaceutical company, launched Belotero Revive, a dermal filler product consisting of hyaluronic acid (HA) and glycerol, designed for improving hydration, elasticity and firmness of the skin by reducing redness and roughness. Hence, such advancements in non-surgical cosmetic treatment is supplementing the growth of dermal fillers facial aesthetics market

The U.S. in North America region is dominating the market as it holds the largest market share in the global dermal filler facial aesthetics market. The growing disposable income coupled with the individual’s increasing expenditure towards aesthetic treatments is expected to drive the demand for dermal filler treatment in North America dermal fillers facial aesthetics market. Asia Pacific is estimated to grow at the highest growth rate over the forecast period. China in Asia Pacific region is expected to be the most attractive for dermal filler facial aesthetics market. In November 2018, Huadong Medicine, Chinese manufacturer of aesthetic products acquired Sinclair Pharma, a UK-based specialty pharma company. The acquisition enabled the company to expand their regional presence and include minimally invasive anti-aging treatments into its product portfolio.


Global Dermal Filler Facial Aesthetics Market Revenue (US$ Million), 2015 – 2027

Global dermal fillers facial aesthetics.jpg

Competitive Landscape

The report provides both, qualitative and quantitative research of global dermal filler facial aesthetics market, as well as provides worthy insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in global dermal fillers facial aesthetics market and detailed insights on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their headquarters, competitors, product/service type, application and specification, pricing, and gross margin.

The primary market participants in the global dermal fillers facial aesthetics market include Allergan Plc, Galderma, Merz Pharma, Teoxane, Sinclair Pharma, DR. Korman, Suneva Medical, Inc., Matex Lab SA (Neauvia), Bohus BioTech AB, BioPlus Co., Ltd., Hangzhou Singclean Medical Products Co.,Ltd, Luminera Derm Ltd, SciVision Biotech Inc., LG Lifesciences, Bloomage Bio Technology Corporation Limited amongst others.

Global Dermal Fillers Facial Aesthetics Market (2015 – 2027)

By Type

  • HA Dermal Fillers
    • Monophasic HA Fillers
    • Biphasic HA Fillers
  • Non-HA Dermal Fillers
    • Polymethylmethacrylate (PMMA) Filler
    • Collagen
    • Poly-L-Lactic Acid (PLLA)
    • Calcium Hydroxylapatite (CaHA)

By Application

  • Wrinkles
  • Lip Enhancement
  • Facial Contouring
  • Glabellar Furrows
  • Peri-Orbital
  • Others (Scars, Crow’s Feet, Etc.)

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Nordic Countries
      • Denmark
      • Finland
      • Iceland
      • Sweden
      • Norway
    • Benelux Union
      • Belgium
      • The Netherlands
      • Luxembourg
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • New Zealand
    • Australia
    • South Korea
    • Southeast Asia
      • Indonesia
      • Thailand
      • Malaysia
      • Singapore
      • Rest of Southeast Asia
    • Rest of Asia Pacific
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Kuwait
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America


Key Questions

Request Sample

Report Customization

Request for Customization

1.    Market Scope

1.1.   Market Segmentation

1.2.   Years Considered

1.2.1. Historic Years: 2013 - 2017

1.2.2. Base Year: 2018

1.2.3. Forecast Years: 2019 – 2027

1.3.   Methodology

1.4.   Assumptions

2.    Key Target Audience

3.    Research Methodology

3.1.   Primary Research

3.1.1. Research Questionnaire

3.1.2. Country-Wise Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2.   Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3.   Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4.   Data Triangulation Methodology

3.5.   Research Assumptions

4.    Recommendations and Insights from AMI’s Perspective**

5.    Holistic Overview of Dermal Fillers Facial Aesthetics Market

6.    Market Synopsis:  Dermal Fillers Facial Aesthetics Market

7.    Dermal Fillers Facial Aesthetics Market: Qualitative Perspective

7.1.   Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2.   Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3.   Trends in Dermal Fillers Facial Aesthetics Market

7.4.   Market Determinants Radar Chart

7.5.   Macro-Economic and Micro-Economic Indicators: Dermal Fillers Facial Aesthetics Market

7.6.   Industry Gross Margin Overview

7.7.   PESTEL Analysis

7.8.   Injection Technique: Dermal Fillers Facial Aesthetics Market

7.9.   Porter’s Five Forces Analysis

7.10. Value Chain Analysis

7.11. Pricing Analysis, By Region (2017 and 2018)

7.11.1. North America

7.11.1.1. U.S

7.11.1.2. Canada

7.11.1.3. Mexico

7.11.2. Europe

7.11.2.1. France

7.11.2.2. The UK

7.11.2.3. Spain

7.11.2.4. Germany

7.11.2.5. Italy

7.11.2.6. Poland

7.11.2.7. Denmark

7.11.2.8. Finland

7.11.2.9. Iceland

7.11.2.10. Norway

7.11.2.11. Sweden

7.11.2.12. Russia

7.11.2.13. Ukraine

7.11.2.14. Belgium

7.11.2.15. The Netherlands

7.11.2.16. Luxembourg

7.11.3. Asia Pacific

7.11.3.1. China

7.11.3.2. Japan

7.11.3.3. India

7.11.3.4. New Zealand

7.11.3.5. Malaysia

7.11.3.6. Taiwan

7.11.3.7. Russia

7.11.3.8. Singapore

7.11.3.9. Hong Kong

7.11.3.10. Australia

7.11.3.11. Southeast Asia

7.11.4. Middle East and Africa

7.11.4.1. GCC Countries

7.11.4.2. UAE

7.11.4.3. Saudi Arabia

7.11.4.4. Southern Africa

7.11.5. Latin America

7.11.5.1. Brazil

7.11.5.2. Argentina

7.12. Marketing Channel, Dermal Fillers Facial Aesthetics Market

7.12.1. Direct Marketing

7.12.2. Indirect Marketing

7.12.3. Marketing Channel Development Trend

7.13. Market Positioning, Dermal Fillers Facial Aesthetics Market

7.13.1. Pricing Strategy

7.13.2. Brand Strategy

7.13.3. Target Client

8.    Global Dermal Fillers Facial Aesthetics Market Analysis and Forecasts, 2018 – 2026

8.1.   Overview

8.1.1. Global Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts

8.2.   Global Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

8.2.1. HA Dermal Fillers

8.2.1.1. Definition

8.2.1.2. Market Penetration, 2018

8.2.1.3. Market Estimation, 2013 – 2018

8.2.1.4. Market Forecast, 2019 – 2027

8.2.1.5. Compound Annual Growth Rate (CAGR)

8.2.1.6. Regional Bifurcation

8.2.1.6.1. North America

8.2.1.6.1.1. Market Estimation, 2013 – 2018

8.2.1.6.1.2. Market Forecast, 2019 – 2027

8.2.1.6.2. Europe

8.2.1.6.2.1. Market Estimation, 2013 – 2018

8.2.1.6.2.2. Market Forecast, 2019 – 2027

8.2.1.6.3. Asia Pacific

8.2.1.6.3.1. Market Estimation, 2013 – 2018

8.2.1.6.3.2. Market Forecast, 2019 – 2027

8.2.1.6.4. Middle East and Africa

8.2.1.6.4.1. Market Estimation, 2013 – 2018

8.2.1.6.4.2. Market Forecast, 2019 – 2027

8.2.1.6.5. Latin America

8.2.1.6.5.1. Market Estimation, 2013 – 2018

8.2.1.6.5.2. Market Forecast, 2019 – 2027

8.2.1.7. Monophasic HA Fillers

8.2.1.7.1. Definition

8.2.1.7.2. Market Penetration, 2018

8.2.1.7.3. Market Estimation, 2013 – 2018

8.2.1.7.4. Market Forecast, 2019 – 2027

8.2.1.7.5. Compound Annual Growth Rate (CAGR)

8.2.1.7.6. Regional Bifurcation

8.2.1.7.7. North America

8.2.1.7.7.1. Market Estimation, 2013 – 2018

8.2.1.7.7.2. Market Forecast, 2019 – 2027

8.2.1.7.8. Europe

8.2.1.7.8.1. Market Estimation, 2013 – 2018

8.2.1.7.8.2. Market Forecast, 2019 – 2027

8.2.1.7.9. Asia Pacific

8.2.1.7.9.1. Market Estimation, 2013 – 2018

8.2.1.7.9.2. Market Forecast, 2019 – 2027

8.2.1.7.10. Middle East and Africa

8.2.1.7.10.1. Market Estimation, 2013 – 2018

8.2.1.7.10.2. Market Forecast, 2019 – 2027

8.2.1.7.11. Latin America

8.2.1.7.11.1. Market Estimation, 2013 – 2018

8.2.1.7.11.2. Market Forecast, 2019 – 2027

8.2.1.8. Biphasic HA Fillers

8.2.1.8.1. Definition

8.2.1.8.2. Market Penetration, 2018

8.2.1.8.3. Market Estimation, 2013 – 2018

8.2.1.8.4. Market Forecast, 2019 – 2027

8.2.1.8.5. Compound Annual Growth Rate (CAGR)

8.2.1.8.6. Regional Bifurcation

8.2.1.8.7. North America

8.2.1.8.7.1. Market Estimation, 2013 – 2018

8.2.1.8.7.2. Market Forecast, 2019 – 2027

8.2.1.8.8. Europe

8.2.1.8.8.1. Market Estimation, 2013 – 2018

8.2.1.8.8.2. Market Forecast, 2019 – 2027

8.2.1.8.9. Asia Pacific

8.2.1.8.9.1. Market Estimation, 2013 – 2018

8.2.1.8.9.2. Market Forecast, 2019 – 2027

8.2.1.8.10. Middle East and Africa

8.2.1.8.10.1. Market Estimation, 2013 – 2018

8.2.1.8.10.2. Market Forecast, 2019 – 2027

8.2.1.8.11. Latin America

8.2.1.8.11.1. Market Estimation, 2013 – 2018

8.2.1.8.11.2. Market Forecast, 2019 – 2027

8.2.2. Non-HA Dermal Fillers

8.2.2.1. Definition

8.2.2.2. Market Penetration, 2018

8.2.2.3. Market Estimation, 2013 – 2018

8.2.2.4. Market Forecast, 2019 – 2027

8.2.2.5. Compound Annual Growth Rate (CAGR)

8.2.2.6. Regional Bifurcation

8.2.2.6.1. North America

8.2.2.6.1.1. Market Estimation, 2013 – 2018

8.2.2.6.1.2. Market Forecast, 2019 – 2027

8.2.2.6.2. Europe

8.2.2.6.2.1. Market Estimation, 2013 – 2018

8.2.2.6.2.2. Market Forecast, 2019 – 2027

8.2.2.6.3. Asia Pacific

8.2.2.6.3.1. Market Estimation, 2013 – 2018

8.2.2.6.3.2. Market Forecast, 2019 – 2027

8.2.2.6.4. Middle East and Africa

8.2.2.6.4.1. Market Estimation, 2013 – 2018

8.2.2.6.4.2. Market Forecast, 2019 – 2027

8.2.2.6.5. Latin America

8.2.2.6.5.1. Market Estimation, 2013 – 2018

8.2.2.6.5.2. Market Forecast, 2019 – 2027

8.2.2.7. Polymethylmethacrylate (PMMA) Filler

8.2.2.7.1. Definition

8.2.2.7.2. Market Penetration, 2018

8.2.2.7.3. Market Estimation, 2013 – 2018

8.2.2.7.4. Market Forecast, 2019 – 2027

8.2.2.7.5. Compound Annual Growth Rate (CAGR)

8.2.2.7.6. Regional Bifurcation

8.2.2.7.7. North America

8.2.2.7.7.1. Market Estimation, 2013 – 2018

8.2.2.7.7.2. Market Forecast, 2019 – 2027

8.2.2.7.8. Europe

8.2.2.7.8.1. Market Estimation, 2013 – 2018

8.2.2.7.8.2. Market Forecast, 2019 – 2027

8.2.2.7.9. Asia Pacific

8.2.2.7.9.1. Market Estimation, 2013 – 2018

8.2.2.7.9.2. Market Forecast, 2019 – 2027

8.2.2.7.10. Middle East and Africa

8.2.2.7.10.1. Market Estimation, 2013 – 2018

8.2.2.7.10.2. Market Forecast, 2019 – 2027

8.2.2.7.11. Latin America

8.2.2.7.11.1. Market Estimation, 2013 – 2018

8.2.2.7.11.2. Market Forecast, 2019 – 2027

8.2.2.8. Collagen

8.2.2.8.1. Definition

8.2.2.8.2. Market Penetration, 2018

8.2.2.8.3. Market Estimation, 2013 – 2018

8.2.2.8.4. Market Forecast, 2019 – 2027

8.2.2.8.5. Compound Annual Growth Rate (CAGR)

8.2.2.8.6. Regional Bifurcation

8.2.2.8.7. North America

8.2.2.8.7.1. Market Estimation, 2013 – 2018

8.2.2.8.7.2. Market Forecast, 2019 – 2027

8.2.2.8.8. Europe

8.2.2.8.8.1. Market Estimation, 2013 – 2018

8.2.2.8.8.2. Market Forecast, 2019 – 2027

8.2.2.8.9. Asia Pacific

8.2.2.8.9.1. Market Estimation, 2013 – 2018

8.2.2.8.9.2. Market Forecast, 2019 – 2027

8.2.2.8.10. Middle East and Africa

8.2.2.8.10.1. Market Estimation, 2013 – 2018

8.2.2.8.10.2. Market Forecast, 2019 – 2027

8.2.2.8.11. Latin America

8.2.2.8.11.1. Market Estimation, 2013 – 2018

8.2.2.8.11.2. Market Forecast, 2019 – 2027

8.2.2.9. Poly-L-Lactic Acid (PLLA)

8.2.2.9.1. Definition

8.2.2.9.2. Market Penetration, 2018

8.2.2.9.3. Market Estimation, 2013 – 2018

8.2.2.9.4. Market Forecast, 2019 – 2027

8.2.2.9.5. Compound Annual Growth Rate (CAGR)

8.2.2.9.6. Regional Bifurcation

8.2.2.9.7. North America

8.2.2.9.7.1. Market Estimation, 2013 – 2018

8.2.2.9.7.2. Market Forecast, 2019 – 2027

8.2.2.9.8. Europe

8.2.2.9.8.1. Market Estimation, 2013 – 2018

8.2.2.9.8.2. Market Forecast, 2019 – 2027

8.2.2.9.9. Asia Pacific

8.2.2.9.9.1. Market Estimation, 2013 – 2018

8.2.2.9.9.2. Market Forecast, 2019 – 2027

8.2.2.9.10. Middle East and Africa

8.2.2.9.10.1. Market Estimation, 2013 – 2018

8.2.2.9.10.2. Market Forecast, 2019 – 2027

8.2.2.9.11. Latin America

8.2.2.9.11.1. Market Estimation, 2013 – 2018

8.2.2.9.11.2. Market Forecast, 2019 – 2027

8.2.2.10. Calcium Hydroxylapatite (CaHA)

8.2.2.10.1. Definition

8.2.2.10.2. Market Penetration, 2018

8.2.2.10.3. Market Estimation, 2013 – 2018

8.2.2.10.4. Market Forecast, 2019 – 2027

8.2.2.10.5. Compound Annual Growth Rate (CAGR)

8.2.2.10.6. Regional Bifurcation

8.2.2.10.7. North America

8.2.2.10.7.1. Market Estimation, 2013 – 2018

8.2.2.10.7.2. Market Forecast, 2019 – 2027

8.2.2.10.8. Europe

8.2.2.10.8.1. Market Estimation, 2013 – 2018

8.2.2.10.8.2. Market Forecast, 2019 – 2027

8.2.2.10.9. Asia Pacific

8.2.2.10.9.1. Market Estimation, 2013 – 2018

8.2.2.10.9.2. Market Forecast, 2019 – 2027

8.2.2.10.10. Middle East and Africa

8.2.2.10.10.1. Market Estimation, 2013 – 2018

8.2.2.10.10.2. Market Forecast, 2019 – 2027

8.2.2.10.11. Latin America

8.2.2.10.11.1. Market Estimation, 2013 – 2018

8.2.2.10.11.2. Market Forecast, 2019 – 2027

8.3.   Key Segment for Channeling Investments

8.3.1. By Type

9.    Global Dermal Fillers Facial Aesthetics Market Analysis and Forecasts, 2018 – 2026

9.1.   Overview

9.2.   Global Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

9.2.1. Wrinkles

9.2.1.1. Definition

9.2.1.2. Market Penetration, 2018

9.2.1.3. Market Estimation, 2013 – 2018

9.2.1.4. Market Forecast, 2019 – 2027

9.2.1.5. Compound Annual Growth Rate (CAGR)

9.2.1.6. Regional Bifurcation

9.2.1.6.1. North America

9.2.1.6.1.1. Market Estimation, 2013 – 2018

9.2.1.6.1.2. Market Forecast, 2019 – 2027

9.2.1.6.2. Europe

9.2.1.6.2.1. Market Estimation, 2013 – 2018

9.2.1.6.2.2. Market Forecast, 2019 – 2027

9.2.1.6.3. Asia Pacific

9.2.1.6.3.1. Market Estimation, 2013 – 2018

9.2.1.6.3.2. Market Forecast, 2019 – 2027

9.2.1.6.4. Middle East and Africa

9.2.1.6.4.1. Market Estimation, 2013 – 2018

9.2.1.6.4.2. Market Forecast, 2019 – 2027

9.2.1.6.5. Latin America

9.2.1.6.5.1. Market Estimation, 2013 – 2018

9.2.1.6.5.2. Market Forecast, 2019 – 2027

9.2.2. Lip Enhancement

9.2.2.1. Definition

9.2.2.2. Market Penetration, 2018

9.2.2.3. Market Estimation, 2013 – 2018

9.2.2.4. Market Forecast, 2019 – 2027

9.2.2.5. Compound Annual Growth Rate (CAGR)

9.2.2.6. Regional Bifurcation

9.2.2.6.1. North America

9.2.2.6.1.1. Market Estimation, 2013 – 2018

9.2.2.6.1.2. Market Forecast, 2019 – 2027

9.2.2.6.2. Europe

9.2.2.6.2.1. Market Estimation, 2013 – 2018

9.2.2.6.2.2. Market Forecast, 2019 – 2027

9.2.2.6.3. Asia Pacific

9.2.2.6.3.1. Market Estimation, 2013 – 2018

9.2.2.6.3.2. Market Forecast, 2019 – 2027

9.2.2.6.4. Middle East and Africa

9.2.2.6.4.1. Market Estimation, 2013 – 2018

9.2.2.6.4.2. Market Forecast, 2019 – 2027

9.2.2.6.5. Latin America

9.2.2.6.5.1. Market Estimation, 2013 – 2018

9.2.2.6.5.2. Market Forecast, 2019 – 2027

9.2.3. Facial Contouring

9.2.3.1. Definition

9.2.3.2. Market Penetration, 2018

9.2.3.3. Market Estimation, 2013 – 2018

9.2.3.4. Market Forecast, 2019 – 2027

9.2.3.5. Compound Annual Growth Rate (CAGR)

9.2.3.6. Regional Bifurcation

9.2.3.6.1. North America

9.2.3.6.1.1. Market Estimation, 2013 – 2018

9.2.3.6.1.2. Market Forecast, 2019 – 2027

9.2.3.6.2. Europe

9.2.3.6.2.1. Market Estimation, 2013 – 2018

9.2.3.6.2.2. Market Forecast, 2019 – 2027

9.2.3.6.3. Asia Pacific

9.2.3.6.3.1. Market Estimation, 2013 – 2018

9.2.3.6.3.2. Market Forecast, 2019 – 2027

9.2.3.6.4. Middle East and Africa

9.2.3.6.4.1. Market Estimation, 2013 – 2018

9.2.3.6.4.2. Market Forecast, 2019 – 2027

9.2.3.6.5. Latin America

9.2.3.6.5.1. Market Estimation, 2013 – 2018

9.2.3.6.5.2. Market Forecast, 2019 – 2027

9.2.4. Glabellar Furrows

9.2.4.1. Definition

9.2.4.2. Market Penetration, 2018

9.2.4.3. Market Estimation, 2013 – 2018

9.2.4.4. Market Forecast, 2019 – 2027

9.2.4.5. Compound Annual Growth Rate (CAGR)

9.2.4.6. Regional Bifurcation

9.2.4.6.1. North America

9.2.4.6.1.1. Market Estimation, 2013 – 2018

9.2.4.6.1.2. Market Forecast, 2019 – 2027

9.2.4.6.2. Europe

9.2.4.6.2.1. Market Estimation, 2013 – 2018

9.2.4.6.2.2. Market Forecast, 2019 – 2027

9.2.4.6.3. Asia Pacific

9.2.4.6.3.1. Market Estimation, 2013 – 2018

9.2.4.6.3.2. Market Forecast, 2019 – 2027

9.2.4.6.4. Middle East and Africa

9.2.4.6.4.1. Market Estimation, 2013 – 2018

9.2.4.6.4.2. Market Forecast, 2019 – 2027

9.2.4.6.5. Latin America

9.2.4.6.5.1. Market Estimation, 2013 – 2018

9.2.4.6.5.2. Market Forecast, 2019 – 2027

9.2.5. Peri-Orbital

9.2.5.1. Definition

9.2.5.2. Market Penetration, 2018

9.2.5.3. Market Estimation, 2013 – 2018

9.2.5.4. Market Forecast, 2019 – 2027

9.2.5.5. Compound Annual Growth Rate (CAGR)

9.2.5.6. Regional Bifurcation

9.2.5.6.1. North America

9.2.5.6.1.1. Market Estimation, 2013 – 2018

9.2.5.6.1.2. Market Forecast, 2019 – 2027

9.2.5.6.2. Europe

9.2.5.6.2.1. Market Estimation, 2013 – 2018

9.2.5.6.2.2. Market Forecast, 2019 – 2027

9.2.5.6.3. Asia Pacific

9.2.5.6.3.1. Market Estimation, 2013 – 2018

9.2.5.6.3.2. Market Forecast, 2019 – 2027

9.2.5.6.4. Middle East and Africa

9.2.5.6.4.1. Market Estimation, 2013 – 2018

9.2.5.6.4.2. Market Forecast, 2019 – 2027

9.2.5.6.5. Latin America

9.2.5.6.5.1. Market Estimation, 2013 – 2018

9.2.5.6.5.2. Market Forecast, 2019 – 2027

9.2.6. Others (Scars, Crow’s Feet, Etc.)

9.2.6.1. Definition

9.2.6.2. Market Penetration, 2018

9.2.6.3. Market Estimation, 2013 – 2018

9.2.6.4. Market Forecast, 2019 – 2027

9.2.6.5. Compound Annual Growth Rate (CAGR)

9.2.6.6. Regional Bifurcation

9.2.6.6.1. North America

9.2.6.6.1.1. Market Estimation, 2013 – 2018

9.2.6.6.1.2. Market Forecast, 2019 – 2027

9.2.6.6.2. Europe

9.2.6.6.2.1. Market Estimation, 2013 – 2018

9.2.6.6.2.2. Market Forecast, 2019 – 2027

9.2.6.6.3. Asia Pacific

9.2.6.6.3.1. Market Estimation, 2013 – 2018

9.2.6.6.3.2. Market Forecast, 2019 – 2027

9.2.6.6.4. Middle East and Africa

9.2.6.6.4.1. Market Estimation, 2013 – 2018

9.2.6.6.4.2. Market Forecast, 2019 – 2027

9.2.6.6.5. Latin America

9.2.6.6.5.1. Market Estimation, 2013 – 2018

9.2.6.6.5.2. Market Forecast, 2019 – 2027

9.3.   Key Segment for Channeling Investments

9.3.1. By Application

10. North America Dermal Fillers Facial Aesthetics Market Analysis and Forecasts, 2018 – 2026

10.1. Overview

10.1.1. North America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)

10.2. North America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

10.2.1. HA Dermal Fillers

10.2.1.1. Monophasic HA Fillers

10.2.1.2. Biphasic HA Fillers

10.2.2. Non-HA Dermal Fillers

10.2.2.1. Polymethylmethacrylate (PMMA) Filler

10.2.2.2. Collagen

10.2.2.3. Poly-L-Lactic Acid (PLLA)

10.2.2.4. Calcium Hydroxylapatite (CaHA)

10.3. North America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

10.3.1. Wrinkles

10.3.2. Lip Enhancement

10.3.3. Facial Contouring

10.3.4. Glabellar Furrows

10.3.5. Peri-Orbital

10.3.6. Others (Scars, Crow’s Feet, Etc.)

10.4. North America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Country

10.4.1. U.S.

10.4.1.1. U.S. Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

10.4.1.1.1. HA Dermal Fillers

10.4.1.1.1.1. Monophasic HA Fillers

10.4.1.1.1.2. Biphasic HA Fillers

10.4.1.1.2. Non-HA Dermal Fillers

10.4.1.1.2.1. Polymethylmethacrylate (PMMA) Filler

10.4.1.1.2.2. Collagen

10.4.1.1.2.3. Poly-L-Lactic Acid (PLLA)

10.4.1.1.2.4. Calcium Hydroxylapatite (CaHA)

10.4.1.2. U.S. Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

10.4.1.2.1. Wrinkles

10.4.1.2.2. Lip Enhancement

10.4.1.2.3. Facial Contouring

10.4.1.2.4. Glabellar Furrows

10.4.1.2.5. Peri-Orbital

10.4.1.2.6. Others (Scars, Crow’s Feet, Etc.)

10.4.2. Canada

10.4.2.1. Canada Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

10.4.2.1.1. HA Dermal Fillers

10.4.2.1.1.1. Monophasic HA Fillers

10.4.2.1.1.2. Biphasic HA Fillers

10.4.2.1.2. Non-HA Dermal Fillers

10.4.2.1.2.1. Polymethylmethacrylate (PMMA) Filler

10.4.2.1.2.2. Collagen

10.4.2.1.2.3. Poly-L-Lactic Acid (PLLA)

10.4.2.1.2.4. Calcium Hydroxylapatite (CaHA)

10.4.2.2. Canada Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

10.4.2.2.1. Wrinkles

10.4.2.2.2. Lip Enhancement

10.4.2.2.3. Facial Contouring

10.4.2.2.4. Glabellar Furrows

10.4.2.2.5. Peri-Orbital

10.4.2.2.6. Others (Scars, Crow’s Feet, Etc.)

10.4.3. Mexico

10.4.3.1. Mexico Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

10.4.3.1.1. HA Dermal Fillers

10.4.3.1.1.1. Monophasic HA Fillers

10.4.3.1.1.2. Biphasic HA Fillers

10.4.3.1.2. Non-HA Dermal Fillers

10.4.3.1.2.1. Polymethylmethacrylate (PMMA) Filler

10.4.3.1.2.2. Collagen

10.4.3.1.2.3. Poly-L-Lactic Acid (PLLA)

10.4.3.1.2.4. Calcium Hydroxylapatite (CaHA)

10.4.3.2. Mexico Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

10.4.3.2.1. Wrinkles

10.4.3.2.2. Lip Enhancement

10.4.3.2.3. Facial Contouring

10.4.3.2.4. Glabellar Furrows

10.4.3.2.5. Peri-Orbital

10.4.3.2.6. Others (Scars, Crow’s Feet, Etc.)

10.4.4. Rest of North America

10.4.4.1. Rest of North America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

10.4.4.1.1. HA Dermal Fillers

10.4.4.1.1.1. Monophasic HA Fillers

10.4.4.1.1.2. Biphasic HA Fillers

10.4.4.1.2. Non-HA Dermal Fillers

10.4.4.1.2.1. Polymethylmethacrylate (PMMA) Filler

10.4.4.1.2.2. Collagen

10.4.4.1.2.3. Poly-L-Lactic Acid (PLLA)

10.4.4.1.2.4. Calcium Hydroxylapatite (CaHA)

10.4.4.2. Rest of North America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

10.4.4.2.1. Wrinkles

10.4.4.2.2. Lip Enhancement

10.4.4.2.3. Facial Contouring

10.4.4.2.4. Glabellar Furrows

10.4.4.2.5. Peri-Orbital

10.4.4.2.6. Others (Scars, Crow’s Feet, Etc.)

10.5. Key Segment for Channeling Investments

10.5.1. By Country

10.5.2. By Type

10.5.3. By Application

11. Europe Dermal Fillers Facial Aesthetics Market Analysis and Forecasts, 2018 – 2026

11.1. Overview

11.1.1. Europe Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)

11.2. Europe Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.2.1. HA Dermal Fillers

11.2.1.1. Monophasic HA Fillers

11.2.1.2. Biphasic HA Fillers

11.2.2. Non-HA Dermal Fillers

11.2.2.1. Polymethylmethacrylate (PMMA) Filler

11.2.2.2. Collagen

11.2.2.3. Poly-L-Lactic Acid (PLLA)

11.2.2.4. Calcium Hydroxylapatite (CaHA)

11.3. Europe Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.3.1. Wrinkles

11.3.2. Lip Enhancement

11.3.3. Facial Contouring

11.3.4. Glabellar Furrows

11.3.5. Peri-Orbital

11.3.6. Others (Scars, Crow’s Feet, Etc.)

11.4. Europe Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Country

11.4.1. France

11.4.1.1. France Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.1.1.1. HA Dermal Fillers

11.4.1.1.1.1. Monophasic HA Fillers

11.4.1.1.1.2. Biphasic HA Fillers

11.4.1.1.2. Non-HA Dermal Fillers

11.4.1.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.1.1.2.2. Collagen

11.4.1.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.1.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.1.2. France Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.1.2.1. Wrinkles

11.4.1.2.2. Lip Enhancement

11.4.1.2.3. Facial Contouring

11.4.1.2.4. Glabellar Furrows

11.4.1.2.5. Peri-Orbital

11.4.1.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.2. The UK

11.4.2.1. The UK Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.2.1.1. HA Dermal Fillers

11.4.2.1.1.1. Monophasic HA Fillers

11.4.2.1.1.2. Biphasic HA Fillers

11.4.2.1.2. Non-HA Dermal Fillers

11.4.2.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.2.1.2.2. Collagen

11.4.2.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.2.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.2.2. The UK Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.2.2.1. Wrinkles

11.4.2.2.2. Lip Enhancement

11.4.2.2.3. Facial Contouring

11.4.2.2.4. Glabellar Furrows

11.4.2.2.5. Peri-Orbital

11.4.2.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.3. Spain

11.4.3.1. Spain Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.3.1.1. HA Dermal Fillers

11.4.3.1.1.1. Monophasic HA Fillers

11.4.3.1.1.2. Biphasic HA Fillers

11.4.3.1.2. Non-HA Dermal Fillers

11.4.3.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.3.1.2.2. Collagen

11.4.3.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.3.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.3.2. Spain Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.3.2.1. Wrinkles

11.4.3.2.2. Lip Enhancement

11.4.3.2.3. Facial Contouring

11.4.3.2.4. Glabellar Furrows

11.4.3.2.5. Peri-Orbital

11.4.3.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.4. Germany

11.4.4.1. Germany Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.4.1.1. HA Dermal Fillers

11.4.4.1.1.1. Monophasic HA Fillers

11.4.4.1.1.2. Biphasic HA Fillers

11.4.4.1.2. Non-HA Dermal Fillers

11.4.4.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.4.1.2.2. Collagen

11.4.4.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.4.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.4.2. Germany Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.4.2.1. Wrinkles

11.4.4.2.2. Lip Enhancement

11.4.4.2.3. Facial Contouring

11.4.4.2.4. Glabellar Furrows

11.4.4.2.5. Peri-Orbital

11.4.4.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.5. Italy

11.4.5.1. Italy Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.5.1.1. HA Dermal Fillers

11.4.5.1.1.1. Monophasic HA Fillers

11.4.5.1.1.2. Biphasic HA Fillers

11.4.5.1.2. Non-HA Dermal Fillers

11.4.5.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.5.1.2.2. Collagen

11.4.5.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.5.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.5.2. Italy Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.5.2.1. Wrinkles

11.4.5.2.2. Lip Enhancement

11.4.5.2.3. Facial Contouring

11.4.5.2.4. Glabellar Furrows

11.4.5.2.5. Peri-Orbital

11.4.5.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.6. Portugal

11.4.6.1. Portugal Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.6.1.1. HA Dermal Fillers

11.4.6.1.1.1. Monophasic HA Fillers

11.4.6.1.1.2. Biphasic HA Fillers

11.4.6.1.2. Non-HA Dermal Fillers

11.4.6.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.6.1.2.2. Collagen

11.4.6.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.6.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.6.2. Portugal Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.6.2.1. Wrinkles

11.4.6.2.2. Lip Enhancement

11.4.6.2.3. Facial Contouring

11.4.6.2.4. Glabellar Furrows

11.4.6.2.5. Peri-Orbital

11.4.6.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.7. Poland

11.4.7.1. Poland Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.7.1.1. HA Dermal Fillers

11.4.7.1.1.1. Monophasic HA Fillers

11.4.7.1.1.2. Biphasic HA Fillers

11.4.7.1.2. Non-HA Dermal Fillers

11.4.7.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.7.1.2.2. Collagen

11.4.7.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.7.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.7.2. Poland Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.7.2.1. Wrinkles

11.4.7.2.2. Lip Enhancement

11.4.7.2.3. Facial Contouring

11.4.7.2.4. Glabellar Furrows

11.4.7.2.5. Peri-Orbital

11.4.7.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.8. Nordic Countries

11.4.8.1. Nordic Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.8.1.1. HA Dermal Fillers

11.4.8.1.1.1. Monophasic HA Fillers

11.4.8.1.1.2. Biphasic HA Fillers

11.4.8.1.2. Non-HA Dermal Fillers

11.4.8.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.8.1.2.2. Collagen

11.4.8.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.8.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.8.2. Nordic Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.8.2.1. Wrinkles

11.4.8.2.2. Lip Enhancement

11.4.8.2.3. Facial Contouring

11.4.8.2.4. Glabellar Furrows

11.4.8.2.5. Peri-Orbital

11.4.8.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.8.3. Nordic Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Country

11.4.8.3.1. Denmark

11.4.8.3.2. Finland

11.4.8.3.3. Sweden

11.4.8.3.4. Iceland

11.4.8.3.5. Norway

11.4.8.3.6. Rest of Nordic

11.4.9. Ukraine

11.4.9.1. Ukraine Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.9.1.1. HA Dermal Fillers

11.4.9.1.1.1. Monophasic HA Fillers

11.4.9.1.1.2. Biphasic HA Fillers

11.4.9.1.2. Non-HA Dermal Fillers

11.4.9.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.9.1.2.2. Collagen

11.4.9.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.9.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.9.2. Ukraine Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.9.2.1. Wrinkles

11.4.9.2.2. Lip Enhancement

11.4.9.2.3. Facial Contouring

11.4.9.2.4. Glabellar Furrows

11.4.9.2.5. Peri-Orbital

11.4.9.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.10. The Benelux Union

11.4.10.1. The Benelux Union Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.10.1.1. HA Dermal Fillers

11.4.10.1.1.1. Monophasic HA Fillers

11.4.10.1.1.2. Biphasic HA Fillers

11.4.10.1.2. Non-HA Dermal Fillers

11.4.10.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.10.1.2.2. Collagen

11.4.10.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.10.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.10.2. The Benelux Union Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.10.2.1. Wrinkles

11.4.10.2.2. Lip Enhancement

11.4.10.2.3. Facial Contouring

11.4.10.2.4. Glabellar Furrows

11.4.10.2.5. Peri-Orbital

11.4.10.2.6. Others (Scars, Crow’s Feet, Etc.)

11.4.10.3. The Benelux Union Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Country

11.4.10.3.1. Wrinkles

11.4.10.3.2. Belgium

11.4.10.3.3. The Netherlands

11.4.10.3.4. Luxemburg

11.4.11. Rest of Europe

11.4.11.1. Rest of Europe Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

11.4.11.1.1. HA Dermal Fillers

11.4.11.1.1.1. Monophasic HA Fillers

11.4.11.1.1.2. Biphasic HA Fillers

11.4.11.1.2. Non-HA Dermal Fillers

11.4.11.1.2.1. Polymethylmethacrylate (PMMA) Filler

11.4.11.1.2.2. Collagen

11.4.11.1.2.3. Poly-L-Lactic Acid (PLLA)

11.4.11.1.2.4. Calcium Hydroxylapatite (CaHA)

11.4.11.2. Rest of Europe Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

11.4.11.2.1. Wrinkles

11.4.11.2.2. Lip Enhancement

11.4.11.2.3. Facial Contouring

11.4.11.2.4. Glabellar Furrows

11.4.11.2.5. Peri-Orbital

11.4.11.2.6. Others (Scars, Crow’s Feet, Etc.)

11.5. Key Segment for Channeling Investments

11.5.1. By Country

11.5.2. By Type

11.5.3. By Application

12. Asia Pacific Dermal Fillers Facial Aesthetics Market Analysis and Forecasts, 2018 – 2026

12.1. Overview

12.1.1. Asia Pacific Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)

12.2. Asia Pacific Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.2.1. HA Dermal Fillers

12.2.1.1. Monophasic HA Fillers

12.2.1.2. Biphasic HA Fillers

12.2.2. Non-HA Dermal Fillers

12.2.2.1. Polymethylmethacrylate (PMMA) Filler

12.2.2.2. Collagen

12.2.2.3. Poly-L-Lactic Acid (PLLA)

12.2.2.4. Calcium Hydroxylapatite (CaHA)

12.3. Asia Pacific Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.3.1. Wrinkles

12.3.2. Lip Enhancement

12.3.3. Facial Contouring

12.3.4. Glabellar Furrows

12.3.5. Peri-Orbital

12.3.6. Others (Scars, Crow’s Feet, Etc.)

12.4. Asia Pacific Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Country

12.4.1. China

12.4.1.1. China Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.1.1.1. HA Dermal Fillers

12.4.1.1.1.1. Monophasic HA Fillers

12.4.1.1.1.2. Biphasic HA Fillers

12.4.1.1.2. Non-HA Dermal Fillers

12.4.1.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.1.1.2.2. Collagen

12.4.1.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.1.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.1.2. China Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.1.2.1. Wrinkles

12.4.1.2.2. Lip Enhancement

12.4.1.2.3. Facial Contouring

12.4.1.2.4. Glabellar Furrows

12.4.1.2.5. Peri-Orbital

12.4.1.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.2. Japan

12.4.2.1. Japan Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.2.1.1. HA Dermal Fillers

12.4.2.1.1.1. Monophasic HA Fillers

12.4.2.1.1.2. Biphasic HA Fillers

12.4.2.1.2. Non-HA Dermal Fillers

12.4.2.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.2.1.2.2. Collagen

12.4.2.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.2.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.2.2. Japan Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.2.2.1. Wrinkles

12.4.2.2.2. Lip Enhancement

12.4.2.2.3. Facial Contouring

12.4.2.2.4. Glabellar Furrows

12.4.2.2.5. Peri-Orbital

12.4.2.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.3. India

12.4.3.1. India Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.3.1.1. HA Dermal Fillers

12.4.3.1.1.1. Monophasic HA Fillers

12.4.3.1.1.2. Biphasic HA Fillers

12.4.3.1.2. Non-HA Dermal Fillers

12.4.3.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.3.1.2.2. Collagen

12.4.3.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.3.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.3.2. India Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.3.2.1. Wrinkles

12.4.3.2.2. Lip Enhancement

12.4.3.2.3. Facial Contouring

12.4.3.2.4. Glabellar Furrows

12.4.3.2.5. Peri-Orbital

12.4.3.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.4. Australia

12.4.4.1. Australia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.4.1.1. HA Dermal Fillers

12.4.4.1.1.1. Monophasic HA Fillers

12.4.4.1.1.2. Biphasic HA Fillers

12.4.4.1.2. Non-HA Dermal Fillers

12.4.4.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.4.1.2.2. Collagen

12.4.4.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.4.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.4.2. Australia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.4.2.1. Wrinkles

12.4.4.2.2. Lip Enhancement

12.4.4.2.3. Facial Contouring

12.4.4.2.4. Glabellar Furrows

12.4.4.2.5. Peri-Orbital

12.4.4.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.5. New Zealand

12.4.5.1. New Zealand Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.5.1.1. HA Dermal Fillers

12.4.5.1.1.1. Monophasic HA Fillers

12.4.5.1.1.2. Biphasic HA Fillers

12.4.5.1.2. Non-HA Dermal Fillers

12.4.5.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.5.1.2.2. Collagen

12.4.5.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.5.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.5.2. New Zealand Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.5.2.1. Wrinkles

12.4.5.2.2. Lip Enhancement

12.4.5.2.3. Facial Contouring

12.4.5.2.4. Glabellar Furrows

12.4.5.2.5. Peri-Orbital

12.4.5.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.6. Hong Kong

12.4.6.1. Hong Kong Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.6.1.1. HA Dermal Fillers

12.4.6.1.1.1. Monophasic HA Fillers

12.4.6.1.1.2. Biphasic HA Fillers

12.4.6.1.2. Non-HA Dermal Fillers

12.4.6.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.6.1.2.2. Collagen

12.4.6.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.6.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.6.2. Hong Kong Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.6.2.1. Wrinkles

12.4.6.2.2. Lip Enhancement

12.4.6.2.3. Facial Contouring

12.4.6.2.4. Glabellar Furrows

12.4.6.2.5. Peri-Orbital

12.4.6.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.7. Singapore

12.4.7.1. Singapore Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.7.1.1. HA Dermal Fillers

12.4.7.1.1.1. Monophasic HA Fillers

12.4.7.1.1.2. Biphasic HA Fillers

12.4.7.1.2. Non-HA Dermal Fillers

12.4.7.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.7.1.2.2. Collagen

12.4.7.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.7.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.7.2. Singapore Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.7.2.1. Wrinkles

12.4.7.2.2. Lip Enhancement

12.4.7.2.3. Facial Contouring

12.4.7.2.4. Glabellar Furrows

12.4.7.2.5. Peri-Orbital

12.4.7.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.8. Taiwan

12.4.8.1. Taiwan Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.8.1.1. HA Dermal Fillers

12.4.8.1.1.1. Monophasic HA Fillers

12.4.8.1.1.2. Biphasic HA Fillers

12.4.8.1.2. Non-HA Dermal Fillers

12.4.8.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.8.1.2.2. Collagen

12.4.8.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.8.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.8.2. Taiwan Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.8.2.1. Wrinkles

12.4.8.2.2. Lip Enhancement

12.4.8.2.3. Facial Contouring

12.4.8.2.4. Glabellar Furrows

12.4.8.2.5. Peri-Orbital

12.4.8.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.9. Malaysia

12.4.9.1. Malaysia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.9.1.1. HA Dermal Fillers

12.4.9.1.1.1. Monophasic HA Fillers

12.4.9.1.1.2. Biphasic HA Fillers

12.4.9.1.2. Non-HA Dermal Fillers

12.4.9.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.9.1.2.2. Collagen

12.4.9.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.9.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.9.2. Malaysia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.9.2.1. Wrinkles

12.4.9.2.2. Lip Enhancement

12.4.9.2.3. Facial Contouring

12.4.9.2.4. Glabellar Furrows

12.4.9.2.5. Peri-Orbital

12.4.9.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.10. Russia

12.4.10.1. Russia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.10.1.1. HA Dermal Fillers

12.4.10.1.1.1. Monophasic HA Fillers

12.4.10.1.1.2. Biphasic HA Fillers

12.4.10.1.2. Non-HA Dermal Fillers

12.4.10.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.10.1.2.2. Collagen

12.4.10.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.10.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.10.2. Russia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.10.2.1. Wrinkles

12.4.10.2.2. Lip Enhancement

12.4.10.2.3. Facial Contouring

12.4.10.2.4. Glabellar Furrows

12.4.10.2.5. Peri-Orbital

12.4.10.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.11. Southeast Asia

12.4.11.1. Southeast Asia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.11.1.1. HA Dermal Fillers

12.4.11.1.1.1. Monophasic HA Fillers

12.4.11.1.1.2. Biphasic HA Fillers

12.4.11.1.2. Non-HA Dermal Fillers

12.4.11.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.11.1.2.2. Collagen

12.4.11.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.11.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.11.2. Southeast Asia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.11.2.1. Wrinkles

12.4.11.2.2. Lip Enhancement

12.4.11.2.3. Facial Contouring

12.4.11.2.4. Glabellar Furrows

12.4.11.2.5. Peri-Orbital

12.4.11.2.6. Others (Scars, Crow’s Feet, Etc.)

12.4.12. Rest of Asia Pacific

12.4.12.1. Rest of Asia Pacific Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

12.4.12.1.1. HA Dermal Fillers

12.4.12.1.1.1. Monophasic HA Fillers

12.4.12.1.1.2. Biphasic HA Fillers

12.4.12.1.2. Non-HA Dermal Fillers

12.4.12.1.2.1. Polymethylmethacrylate (PMMA) Filler

12.4.12.1.2.2. Collagen

12.4.12.1.2.3. Poly-L-Lactic Acid (PLLA)

12.4.12.1.2.4. Calcium Hydroxylapatite (CaHA)

12.4.12.2. Rest of Asia Pacific Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

12.4.12.2.1. Wrinkles

12.4.12.2.2. Lip Enhancement

12.4.12.2.3. Facial Contouring

12.4.12.2.4. Glabellar Furrows

12.4.12.2.5. Peri-Orbital

12.4.12.2.6. Others (Scars, Crow’s Feet, Etc.)

12.5. Key Segment for Channeling Investments

12.5.1. By Country

12.5.2. By Type

12.5.3. By Application

13. Middle East and Africa Dermal Fillers Facial Aesthetics Market Analysis and Forecasts, 2018 – 2026

13.1. Overview

13.1.1. Middle East and Africa Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)

13.2. Middle East and Africa Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

13.2.1. HA Dermal Fillers

13.2.1.1. Monophasic HA Fillers

13.2.1.2. Biphasic HA Fillers

13.2.2. Non-HA Dermal Fillers

13.2.2.1. Polymethylmethacrylate (PMMA) Filler

13.2.2.2. Collagen

13.2.2.3. Poly-L-Lactic Acid (PLLA)

13.2.2.4. Calcium Hydroxylapatite (CaHA)

13.3. Middle East and Africa Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

13.3.1. Wrinkles

13.3.2. Lip Enhancement

13.3.3. Facial Contouring

13.3.4. Glabellar Furrows

13.3.5. Peri-Orbital

13.3.6. Others (Scars, Crow’s Feet, Etc.)

13.4. Middle East and Africa Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Country

13.4.1. GCC Countries

13.4.1.1. GCC Countries Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

13.4.1.1.1. HA Dermal Fillers

13.4.1.1.1.1. Monophasic HA Fillers

13.4.1.1.1.2. Biphasic HA Fillers

13.4.1.1.2. Non-HA Dermal Fillers

13.4.1.1.2.1. Polymethylmethacrylate (PMMA) Filler

13.4.1.1.2.2. Collagen

13.4.1.1.2.3. Poly-L-Lactic Acid (PLLA)

13.4.1.1.2.4. Calcium Hydroxylapatite (CaHA)

13.4.1.2. GCC Countries Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

13.4.1.2.1. Wrinkles

13.4.1.2.2. Lip Enhancement

13.4.1.2.3. Facial Contouring

13.4.1.2.4. Glabellar Furrows

13.4.1.2.5. Peri-Orbital

13.4.1.2.6. Others (Scars, Crow’s Feet, Etc.)

13.4.2. UAE

13.4.2.1. UAE Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

13.4.2.1.1. HA Dermal Fillers

13.4.2.1.1.1. Monophasic HA Fillers

13.4.2.1.1.2. Biphasic HA Fillers

13.4.2.1.2. Non-HA Dermal Fillers

13.4.2.1.2.1. Polymethylmethacrylate (PMMA) Filler

13.4.2.1.2.2. Collagen

13.4.2.1.2.3. Poly-L-Lactic Acid (PLLA)

13.4.2.1.2.4. Calcium Hydroxylapatite (CaHA)

13.4.2.2. UAE Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

13.4.2.2.1. Wrinkles

13.4.2.2.2. Lip Enhancement

13.4.2.2.3. Facial Contouring

13.4.2.2.4. Glabellar Furrows

13.4.2.2.5. Peri-Orbital

13.4.2.2.6. Others (Scars, Crow’s Feet, Etc.)

13.4.3. Saudi Arabia

13.4.3.1. Saudi Arabia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

13.4.3.1.1. HA Dermal Fillers

13.4.3.1.1.1. Monophasic HA Fillers

13.4.3.1.1.2. Biphasic HA Fillers

13.4.3.1.2. Non-HA Dermal Fillers

13.4.3.1.2.1. Polymethylmethacrylate (PMMA) Filler

13.4.3.1.2.2. Collagen

13.4.3.1.2.3. Poly-L-Lactic Acid (PLLA)

13.4.3.1.2.4. Calcium Hydroxylapatite (CaHA)

13.4.3.2. Saudi Arabia Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

13.4.3.2.1. Wrinkles

13.4.3.2.2. Lip Enhancement

13.4.3.2.3. Facial Contouring

13.4.3.2.4. Glabellar Furrows

13.4.3.2.5. Peri-Orbital

13.4.3.2.6. Others (Scars, Crow’s Feet, Etc.)

13.4.4. Southern Africa

13.4.4.1. Southern Africa Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

13.4.4.1.1. HA Dermal Fillers

13.4.4.1.1.1. Monophasic HA Fillers

13.4.4.1.1.2. Biphasic HA Fillers

13.4.4.1.2. Non-HA Dermal Fillers

13.4.4.1.2.1. Polymethylmethacrylate (PMMA) Filler

13.4.4.1.2.2. Collagen

13.4.4.1.2.3. Poly-L-Lactic Acid (PLLA)

13.4.4.1.2.4. Calcium Hydroxylapatite (CaHA)

13.4.4.2. Southern Africa Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

13.4.4.2.1. Wrinkles

13.4.4.2.2. Lip Enhancement

13.4.4.2.3. Facial Contouring

13.4.4.2.4. Glabellar Furrows

13.4.4.2.5. Peri-Orbital

13.4.4.2.6. Others (Scars, Crow’s Feet, Etc.)

13.4.5. Rest of MEA

13.4.5.1. Rest of MEA Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

13.4.5.1.1. HA Dermal Fillers

13.4.5.1.1.1. Monophasic HA Fillers

13.4.5.1.1.2. Biphasic HA Fillers

13.4.5.1.2. Non-HA Dermal Fillers

13.4.5.1.2.1. Polymethylmethacrylate (PMMA) Filler

13.4.5.1.2.2. Collagen

13.4.5.1.2.3. Poly-L-Lactic Acid (PLLA)

13.4.5.1.2.4. Calcium Hydroxylapatite (CaHA)

13.4.5.2. Rest of MEA Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

13.4.5.2.1. Wrinkles

13.4.5.2.2. Lip Enhancement

13.4.5.2.3. Facial Contouring

13.4.5.2.4. Glabellar Furrows

13.4.5.2.5. Peri-Orbital

13.4.5.2.6. Others (Scars, Crow’s Feet, Etc.)

13.5. Key Segment for Channeling Investments

13.5.1. By Country

13.5.2. By Type

13.5.3. By Application

14. Latin America Dermal Fillers Facial Aesthetics Market Analysis and Forecasts, 2018 – 2026

14.1. Overview

14.1.1. Latin America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)

14.2. Latin America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

14.2.1. HA Dermal Fillers

14.2.1.1. Monophasic HA Fillers

14.2.1.2. Biphasic HA Fillers

14.2.2. Non-HA Dermal Fillers

14.2.2.1. Polymethylmethacrylate (PMMA) Filler

14.2.2.2. Collagen

14.2.2.3. Poly-L-Lactic Acid (PLLA)

14.2.2.4. Calcium Hydroxylapatite (CaHA)

14.3. Latin America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

14.3.1. Wrinkles

14.3.2. Lip Enhancement

14.3.3. Facial Contouring

14.3.4. Glabellar Furrows

14.3.5. Peri-Orbital

14.3.6. Others (Scars, Crow’s Feet, Etc.)

14.4. Latin America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Country

14.4.1. Brazil

14.4.1.1. Brazil Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

14.4.1.1.1. HA Dermal Fillers

14.4.1.1.1.1. Monophasic HA Fillers

14.4.1.1.1.2. Biphasic HA Fillers

14.4.1.1.2. Non-HA Dermal Fillers

14.4.1.1.2.1. Polymethylmethacrylate (PMMA) Filler

14.4.1.1.2.2. Collagen

14.4.1.1.2.3. Poly-L-Lactic Acid (PLLA)

14.4.1.1.2.4. Calcium Hydroxylapatite (CaHA)

14.4.1.2. Brazil Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

14.4.1.2.1. Wrinkles

14.4.1.2.2. Lip Enhancement

14.4.1.2.3. Facial Contouring

14.4.1.2.4. Glabellar Furrows

14.4.1.2.5. Peri-Orbital

14.4.1.2.6. Others (Scars, Crow’s Feet, Etc.)

14.4.2. Argentina

14.4.2.1. Argentina Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

14.4.2.1.1. HA Dermal Fillers

14.4.2.1.1.1. Monophasic HA Fillers

14.4.2.1.1.2. Biphasic HA Fillers

14.4.2.1.2. Non-HA Dermal Fillers

14.4.2.1.2.1. Polymethylmethacrylate (PMMA) Filler

14.4.2.1.2.2. Collagen

14.4.2.1.2.3. Poly-L-Lactic Acid (PLLA)

14.4.2.1.2.4. Calcium Hydroxylapatite (CaHA)

14.4.2.2. Argentina Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

14.4.2.2.1. Wrinkles

14.4.2.2.2. Lip Enhancement

14.4.2.2.3. Facial Contouring

14.4.2.2.4. Glabellar Furrows

14.4.2.2.5. Peri-Orbital

14.4.2.2.6. Others (Scars, Crow’s Feet, Etc.)

14.4.3. Rest of Latin America

14.4.3.1. Rest of Latin America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Type

14.4.3.1.1. HA Dermal Fillers

14.4.3.1.1.1. Monophasic HA Fillers

14.4.3.1.1.2. Biphasic HA Fillers

14.4.3.1.2. Non-HA Dermal Fillers

14.4.3.1.2.1. Polymethylmethacrylate (PMMA) Filler

14.4.3.1.2.2. Collagen

14.4.3.1.2.3. Poly-L-Lactic Acid (PLLA)

14.4.3.1.2.4. Calcium Hydroxylapatite (CaHA)

14.4.3.2. Rest of Latin America Dermal Fillers Facial Aesthetics Market Volume and Revenue (US$ Mn and Units)  and Forecasts, By Application

14.4.3.2.1. Wrinkles

14.4.3.2.2. Lip Enhancement

14.4.3.2.3. Facial Contouring

14.4.3.2.4. Glabellar Furrows

14.4.3.2.5. Peri-Orbital

14.4.3.2.6. Others (Scars, Crow’s Feet, Etc.)

14.5. Key Segment for Channeling Investments

14.5.1. By Country

14.5.2. By Type

14.5.3. By Application

15. Competitive Benchmarking

15.1. Player Positioning Analysis

15.2. Global Presence and Growth Strategies

16. Player Profiles

16.1. Allergan Plc.

16.1.1. Company Details

16.1.2. Company Overview

16.1.3. Product Offerings

16.1.4. Key Developments

16.1.5. Financial Analysis

16.1.6. SWOT Analysis

16.1.7. Business Strategies

16.2. Bloomage BioTechnology Corporation Limited

16.2.1. Company Details

16.2.2. Company Overview

16.2.3. Product Offerings

16.2.4. Key Developments

16.2.5. Financial Analysis

16.2.6. SWOT Analysis

16.2.7. Business Strategies

16.3. Bohus BioTech AB

16.3.1. Company Details

16.3.2. Company Overview

16.3.3. Product Offerings

16.3.4. Key Developments

16.3.5. Financial Analysis

16.3.6. SWOT Analysis

16.3.7. Business Strategies

16.4. Matex Lab SA (Neauvia)

16.4.1. Company Details

16.4.2. Company Overview

16.4.3. Product Offerings

16.4.4. Key Developments

16.4.5. Financial Analysis

16.4.6. SWOT Analysis

16.4.7. Business Strategies

16.5. DR. Korman

16.5.1. Company Details

16.5.2. Company Overview

16.5.3. Product Offerings

16.5.4. Key Developments

16.5.5. Financial Analysis

16.5.6. SWOT Analysis

16.5.7. Business Strategies

16.6. Sinclair Pharma

16.6.1. Company Details

16.6.2. Company Overview

16.6.3. Product Offerings

16.6.4. Key Developments

16.6.5. Financial Analysis

16.6.6. SWOT Analysis

16.6.7. Business Strategies

16.7. Galderma S.A.

16.7.1. Company Details

16.7.2. Company Overview

16.7.3. Product Offerings

16.7.4. Key Developments

16.7.5. Financial Analysis

16.7.6. SWOT Analysis

16.7.7. Business Strategies

16.8. Hangzhou Singclean Medical Products Co.,Ltd

16.8.1. Company Details

16.8.2. Company Overview

16.8.3. Product Offerings

16.8.4. Key Developments

16.8.5. Financial Analysis

16.8.6. SWOT Analysis

16.8.7. Business Strategies

16.9. LG Lifesciences

16.9.1. Company Details

16.9.2. Company Overview

16.9.3. Product Offerings

16.9.4. Key Developments

16.9.5. Financial Analysis

16.9.6. SWOT Analysis

16.9.7. Business Strategies

16.10.   Luminera Derm Ltd

16.10.1. Company Details

16.10.2. Company Overview

16.10.3. Product Offerings

16.10.4. Key Developments

16.10.5. Financial Analysis

16.10.6. SWOT Analysis

16.10.7. Business Strategies

16.11.   Merz Pharma

16.11.1. Company Details

16.11.2. Company Overview

16.11.3. Product Offerings

16.11.4. Key Developments

16.11.5. Financial Analysis

16.11.6. SWOT Analysis

16.11.7. Business Strategies

16.12.   SciVision Biotech Inc.

16.12.1. Company Details

16.12.2. Company Overview

16.12.3. Product Offerings

16.12.4. Key Developments

16.12.5. Financial Analysis

16.12.6. SWOT Analysis

16.12.7. Business Strategies

16.13.   Suneva Medical, Inc.

16.13.1. Company Details

16.13.2. Company Overview

16.13.3. Product Offerings

16.13.4. Key Developments

16.13.5. Financial Analysis

16.13.6. SWOT Analysis

16.13.7. Business Strategies

16.14.   TEOXANE Laboratories

16.14.1. Company Details

16.14.2. Company Overview

16.14.3. Product Offerings

16.14.4. Key Developments

16.14.5. Financial Analysis

16.14.6. SWOT Analysis

16.14.7. Business Strategies

17. Key Findings

 

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

**Exclusive for Multi-User and Enterprise User

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

Research Methodology

Methodology

Key Inclusions

Methodology

  • A PHP Error was encountered

    Severity: Notice

    Message: Undefined offset: 0

    Filename: pages/reportpage.php

    Line Number: 163

    Backtrace:

    File: /var/www/html/ami/application/views/pages/reportpage.php
    Line: 163
    Function: _error_handler

    File: /var/www/html/ami/application/controllers/Report.php
    Line: 153
    Function: view

    File: /var/www/html/ami/index.php
    Line: 315
    Function: require_once